APLS
Apellis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$41.03
+0.00%Leverage
- Debt / equity
- 1.15x
- Net debt / equity
- 0.17x
- Debt / assets
- 0.44x
- Debt / EBITDA
- 2.69x
- Net debt / EBITDA
- 0.39x
Liquidity & coverage
- Current ratio
- 3.63x
- Quick ratio
- 3.16x
- Cash ratio
- 1.43x
- Interest coverage
- 3.79x
- EBITDA / interest
- 4.06x
- Working capital
- $744.6M
Cash & dividend
- FCF / debt
- 0.08x
- Cash flow / debt
- 0.08x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026